METHODIST HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.5M
- Transactions
- 586
- Companies
- 40
- Average per transaction
- $11,008
Who reported the payments
| Vertex | $1,985,715 |
| Gilead | $1,148,835 |
| Jazz Pharmaceuticals Inc. | $509,639 |
| Abbott | $324,253 |
| Johnson & Johnson | $285,717 |
| Medtronic | $236,302 |
| Novartis | $196,240 |
| Cardiofocus, Inc. | $186,331 |
| National Marrow Donor Program | $160,505 |
| Acutus Medical, Inc. | $139,500 |
| Pfizer | $116,566 |
| Actelion Pharmaceuticals, Ltd | $114,251 |
| Angiodynamics, Inc. | $97,833 |
| Haemonetics Corporation | $82,452 |
| Sanofi US Services Inc. | $80,337 |
| CSL Behring | $71,412 |
| Celularity Inc. | $65,706 |
| Incyte Corporation | $61,891 |
| Janssen Research & Development, LLC | $46,460 |
| Boston Scientific | $38,125 |
| Aesculap, Inc. | $35,855 |
| Impulse Dynamics (USA) Inc. | $33,960 |
| Intuitive Surgical | $28,826 |
| Merck | $22,603 |
| Mallinckrodt Enterprises LLC | $19,866 |
| Scientia Vascular | $17,550 |
| ZOLL Respicardia, Inc. | $17,071 |
| Linvatec Corporation | $16,676 |
| Acera Surgical, Inc. | $16,533 |
| KCI USA, Inc. | $16,500 |
| Actelion Pharmaceuticals US, Inc. | $16,375 |
| Genentech USA, Inc. | $15,000 |
| Amgen | $14,600 |
| Zimmer Biomet | $13,789 |
| Astrazeneca UK Limited | $13,740 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,500 |
| Shockwave Medical, Inc | $12,913 |
| Ivoclar Vivadent, Inc. | $11,223 |
| B. Braun Interventional Systems Inc. | $10,773 |
| Pharmacyclics LLC, An Abbvie Company | $10,000 |